No Data
No Data
Express News | Hunan Jiudian Pharmaceutical: Chemically-based adhesive ointments still have a lot of room for growth in the future.
Hunan Jiudian Pharmaceutical (300705): The integration of chemical medicine, gel and patch products is a promising prospect for the future global strategy.
Event: Company released the 2023 annual report and the first quarter report for 2024. The company achieved revenue of 2.693 billion yuan in 2023, a year-on-year increase of 15.75%, with a net income attributable to the parent company of 368 million yuan, a year-on-year increase of 36.54%.
Express News | Jiudian Pharmaceutical: Obtaining a Notice of Approval for Clinical Trials of Effluprofen Patches
Ping An Securities: The terminal market resumes growth and selects varieties based on space and pattern
Ping An Securities released a research report saying that judging from changes in the scale and pattern of terminal drug use, the industry ushered in restorative growth in the post-pandemic era. Innovative drugs and varieties with high barriers and good patterns are growing faster than the overall growth rate.
Jiudian Pharmaceutical (300705.SZ): Currently, loxoprofen sodium gel patch is piloting a semi-self-operated model in the three provinces of Henan, Shandong and Hunan. The pilot situation is good
Gelonghui, May 21丨Jiudian Pharmaceutical (300705.SZ) recently received a survey on specific subjects. “Will the number of pilot provinces for the company's loxoprofen sodium gel patch model increase?” The company replied that currently, loxoprofen sodium gel patch is piloting a semi-self-operated model in the three provinces of Henan, Shandong, and Hunan, and the pilot situation is good. According to market conditions and sales plans, the company will consider whether to adjust the provinces that adopt the semi-self-operated model.
Jiudian Pharmaceutical (300705.SZ): Jiao Qi Musk Gel Patch completed the declared production in December 2023 and is expected to be approved in 2025
Gelonghui, May 21丨Jiudian Pharmaceutical (300705.SZ) recently received a survey on “Expected marketing time and promotion plan for the traditional Chinese medicine gel paste pepper Qimusk?” The company replied that the production of Jiaoqi Musk Gel Patch has been declared for production in December 2023 and is expected to be approved in 2025. The sales channels for this product are still mainly in-hospital channels. The focus is on supporting hospital development, hoping to set it as a benchmark for new traditional Chinese medicine pastes.
No Data